Clinical trial
Effects of Terlipressin Added to Usual Care vs. Usual Care Alone on Renal Perfusion in Patients With Septic Shock
NCT04948372 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Terlipressin Added to Usual Care vs. Usual Care Alone on Renal Perfusion in Patients With Septic Shock
- Lead sponsor
- Southeast University, China
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- June 28, 2020
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock